DIETARY AND/OR PHYSICAL ACTIVITY INTERVENTIONS IN WOMEN WITH OVERWEIGHT OR OBESITY PRIOR TO FERTILITY TREATMENT: PROTOCOL FOR A SYSTEMATIC REVIEW AND INDIVIDUAL PARTICIPANT DATA META-ANALYSIS

Evans-Hoeker E, Wang Z, Groen H, Cantineau AEP, Thurin-Kjellberg A, Bergh C, Laven JSE, Dietz de Loos A, Jiskoot G, Baillargeon JP, Palomba S, Sim K, Moran LJ, Espinós JJ, Moholdt T, Rothberg AE, Shoupe D, Hoek A, Legro RS, Mol BW, Wang R; Venus-IPD Collaboration. Dietary and/or physical activity interventions in women with overweight or obesity prior to fertility treatment: protocol for a systematic review and individual participant data meta-analysis. BMJ Open. 2022 Nov 7;12(11):e065206. doi: 10.1136/bmjopen-2022-065206. PMID: 36344004; PMCID: PMC9644352.

The Venus-IPD group presents a protocol to establish a meta-analysis to understand the effectiveness and safety of dietary and/or physical activity interventions in overweight or obese women prior to beginning fertility treatments. Data will be gathered from retrospective cohort studies that involved dietary and/or physical activity interventions and compared outcomes from patients who received standard advice concerning healthy lifestyle to patients without intervention. Quasi-RCTs and women who underwent bariatric surgery are to be excluded. Studies will be identified from the following databases: MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). Leading authors from the included studies will receive a list of requested data. The main analysis will be based on the intention-to-treat principle. Results from this study have the potential to advise clinicians on the value of postposing fertility treatment for overweight or obese women to receive dietary and/or physical activity interventions to improve reproductive, maternal, and perinatal outcomes.

Previous
Previous

ANTIOXIDANT INTERVENTION AGAINST MALE INFERTILITY: TIME TO DESIGN NOVEL STRATEGIES

Next
Next

LIVE-BIRTH OUTCOMES AMONG WOMEN WITH INFERTILITY AND ANTI-MÜLLERIAN HORMONE LEVELS OF 0.3 NG/ML OR LOWER